Literature DB >> 23094953

Facilitating medical withdrawal from opiates in rural Ontario.

N Kiepek1, L Hancock, D Toppozini, H Cromarty, A Morgan, L Kelly.   

Abstract

CONTEXT: The abuse of oxycodone in Northwestern Ontario, Canada, has escalated at alarming rates raising concerns that opiate use has reached epidemic proportions, particularly among the First Nations communities. The authors were involved in establishing Ontario's first rural inpatient medical withdrawal unit to serve patients seeking abstinence. ISSUES: The development of the medical withdrawal support services (MWSS) required creative and adaptive strategies to respond to the geographical, cultural and institutional circumstances. LESSONS LEARNED: Key factors to support program efficacy and successful outcomes for clients during the inaugural eight months of operation are interprofessional and collaborative approaches with a cultural awareness.Key words: addiction, Canada, First Nation, medical withdrawal.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23094953

Source DB:  PubMed          Journal:  Rural Remote Health        ISSN: 1445-6354            Impact factor:   1.759


  11 in total

1.  Oxford House Residents' Attitudes Toward Medication Assisted Treatment Use in Fellow Residents.

Authors:  John M Majer; Christopher Beasley; Emily Stecker; Ted J Bobak; Joshua Norris; Hai Minh Nguyen; Maisie Ogata; Jordana Siegel; Elzbieta Wiedbusch; Isabel Dovale; Noah Gelfman; Sarah Callahan; Leonard A Jason
Journal:  Community Ment Health J       Date:  2018-01-04

2.  A Retrospective Cohort Study Comparing In-Person and Telemedicine-Based Opioid Agonist Treatment in Ontario, Canada, Using Administrative Health Data.

Authors:  Kristen A Morin; Matthiew D Parrotta; Joseph K Eibl; David C Marsh
Journal:  Eur Addict Res       Date:  2021-03-11       Impact factor: 3.015

Review 3.  The management of opioid dependence during pregnancy in rural and remote settings.

Authors:  Naana Afua Jumah; Lisa Graves; Meldon Kahan
Journal:  CMAJ       Date:  2014-10-06       Impact factor: 8.262

4.  Incidence of narcotic abuse during pregnancy in northwestern Ontario: three-year prospective cohort study.

Authors:  Len Kelly; John Guilfoyle; Joe Dooley; Irwin Antone; Lianne Gerber-Finn; Roisin Dooley; Nicole Brunton; Kara Kakegamuck; Jill Muileboom; Wilma Hopman; Helen Cromarty; Barb Linkewich; Jennifer Maki
Journal:  Can Fam Physician       Date:  2014-10       Impact factor: 3.275

5.  Evaluating the Effectiveness of First-Time Methadone Maintenance Therapy Across Northern, Rural, and Urban Regions of Ontario, Canada.

Authors:  Joseph K Eibl; Tara Gomes; Diana Martins; Ximena Camacho; David N Juurlink; Muhammad M Mamdani; Irfan A Dhalla; David C Marsh
Journal:  J Addict Med       Date:  2015 Nov-Dec       Impact factor: 3.702

6.  Too much or never enough: a response to Treatment of opioid disorders in Canada: looking at the 'other epidemic'.

Authors:  Joseph K Eibl; Kristen A Morin-Taus; David C Marsh
Journal:  Subst Abuse Treat Prev Policy       Date:  2016-09-20

7.  The opioid crisis: past, present and future policy climate in Ontario, Canada.

Authors:  Kristen A Morin; Joseph K Eibl; Alexandra M Franklyn; David C Marsh
Journal:  Subst Abuse Treat Prev Policy       Date:  2017-11-02

8.  General practitioners and management of chronic noncancer pain: a cross-sectional survey of influences on opioid deprescribing.

Authors:  Ruth White; Chris Hayes; Allison W Boyes; Simon Chiu; Christine L Paul
Journal:  J Pain Res       Date:  2019-01-22       Impact factor: 3.133

9.  Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada.

Authors:  Kristen A Morin; Joseph K Eibl; Joseph M Caswell; Graham Gauthier; Brian Rush; Christopher Mushquash; Nancy E Lightfoot; David C Marsh
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-06-26

10.  Measuring treatment attrition at various stages of engagement in Opioid Agonist Treatment in Ontario Canada using a cascade of care framework.

Authors:  Farah Tahsin; Kristen A Morin; Frank Vojtesek; David C Marsh
Journal:  BMC Health Serv Res       Date:  2022-04-12       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.